Literature DB >> 9174202

Candida norvegensis: a fluconazole-resistant species.

P Sandven1, K Nilsen, A Digranes, T Tjade, J Lassen.   

Abstract

Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the fluconazole resistance is inherent.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9174202      PMCID： PMC163918          DOI： 10.1128/AAC.41.6.1375

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  [Study of a Norwegian collection of yeasts].

Authors:  E DIETRICHSON
Journal:  Ann Parasitol Hum Comp       Date:  1954

2.  Isolation of Candida norvegensis from clinical specimens: four case reports.

Authors:  S V Hood; C B Moore; D W Denning
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 3.  Standardization of antifungal susceptibility testing.

Authors:  M G Cormican; M A Pfaller
Journal:  J Antimicrob Chemother       Date:  1996-10       Impact factor: 5.790

4.  Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.

Authors:  H Nielsen; J Stenderup; B Bruun; J Ladefoged
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  Invasive Candida norvegensis infection in immunocompromised patients.

Authors:  H Nielsen; J Stenderup
Journal:  Scand J Infect Dis       Date:  1996

6.  Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; A L Barry
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948
  6 in total
  8 in total

1.  Candidemia in Norway (1991 to 2003): results from a nationwide study.

Authors:  Per Sandven; Lars Bevanger; Asbjørn Digranes; Hanne H Haukland; Turid Mannsåker; Peter Gaustad
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Growth of Candida norvegensis (strain Levazoot 15) with different energy, nitrogen, vitamin, and micromineral sources.

Authors:  C Angulo-Montoya; O Ruiz Barrera; Y Castillo-Castillo; Y Marrero-Rodriguez; A Elias-Iglesias; A Estrada-Angulo; G Contreras-Pérez; C Arzola-Álvarez; L Carlos-Valdez
Journal:  Braz J Microbiol       Date:  2018-11-29       Impact factor: 2.476

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

5.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; D Ellis; V Tullio; A Rodloff; W Fu; T A Ling
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

6.  Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures.

Authors:  L Majoros; G Kardos; A Belák; A Maráz; L Asztalos; E Csánky; Z Barta; B Szabó
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Mohammad Kord; Maryam Roudbary; Hossein Zarrinfar; Wenjie Fang; Sayed Jamal Hashemi; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Weihua Pan; Wanqing Liao; Hamid Badali; Sassan Rezaie; Kamiar Zomorodian; Ferry Hagen; Teun Boekhout
Journal:  Front Cell Infect Microbiol       Date:  2019-02-15       Impact factor: 5.293

8.  Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review.

Authors:  Maria Musso; Maddalena Giannella; Mario Antonini; Eugenio Bordi; Giuseppe Maria Ettorre; Loretta Tessitore; Andrea Mariano; Alessandro Capone
Journal:  Infect Dis Rep       Date:  2014-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.